U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Cover of Drugs and Lactation Database (LactMed®)

Drugs and Lactation Database (LactMed®) [Internet].

Show details

Polythiazide

Last Revision: February 7, 2019.

Estimated reading time: 1 minute

CASRN: 346-18-9

Chemical structure

Drug Levels and Effects

Summary of Use during Lactation

No information is available on the amount of polythiazide in breastmilk. Intense diuresis with large doses may decrease breastmilk production. Other diuretics in low doses are preferred over polythiazide.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Polythiazide 2 mg was given twice daily for 8 days beginning within 24 hours of delivery to suppress postpartum lactation. Patients also had breast binding for at least 10 days and fluid restriction. The authors reported that this technique was effective in 124 cases reviewed.[1] There are no data on the effects of diuretics on established lactation.

Alternate Drugs to Consider

Chlorothiazide, Hydrochlorothiazide

References

1.
Timmermans HL. [Use of P 2525 or polythiazide as suppressor of lactation during post-partum]. Brux Med. 1963;43:1051-6. [PubMed: 14095820]

Substance Identification

Substance Name

Polythiazide

CAS Registry Number

346-18-9

Drug Class

  • Breast Feeding
  • Antihypertensive Agents
  • Thiazide Diuretics

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK501075PMID: 30000134

Views

Related information

Similar articles in PubMed

  • Review Methyclothiazide.[Drugs and Lactation Database (...]
    Review Methyclothiazide.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Benzthiazide.[Drugs and Lactation Database (...]
    Review Benzthiazide.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Trichlormethiazide.[Drugs and Lactation Database (...]
    Review Trichlormethiazide.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Hydroflumethiazide.[Drugs and Lactation Database (...]
    Review Hydroflumethiazide.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Bendroflumethiazide.[Drugs and Lactation Database (...]
    Review Bendroflumethiazide.
    . Drugs and Lactation Database (LactMed®). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...